Accentia extends warrants issued in February private placement

By Laura Lutz

Des Moines, Sept. 21 - Accentia Biopharmaceuticals, Inc. extended the expiration of the warrants issued in a February 2007 private placement to Sept. 28 from Sept. 17, according to an 8-K filing with the Securities and Exchange Commission.

The warrants were issued as part of a $24.7 million private placement of 8% convertible debentures.

Tampa, Fla.-based Accentia develops late-stage clinical products, mostly for drugs that have already been approved, in new formulations or indications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.